Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Prostatic Neoplasms 3Spinal Cord Compression 1Sleep Apnea, Obstructive 1Sleep Apnea Syndromes 1Recurrence 1Postoperative Complications 1Polycystic Ovary Syndrome 1Pancreatic Neoplasms 1Obesity 1Neoplasms 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1COVID-19 1Brain Neoplasms 1Arthritis, Rheumatoid 1

Interventions

Carboplatin 346Cisplatin 240Paclitaxel 208Radiotherapy 207Pemetrexed 190Docetaxel 170Gemcitabine 158pembrolizumab 147Erlotinib Hydrochloride 111Magnetic Resonance Spectroscopy 102Etoposide 99Bevacizumab 96Specimen Handling 84Nivolumab 77Radiosurgery 74durvalumab 73Blood Specimen Collection 65Drug Therapy 61osimertinib 56Vinorelbine 54Gefitinib 50Surveys and Questionnaires 48atezolizumab 45Biopsy 43Radiation 42Irinotecan 42Topotecan 39Standard of Care 39Cyclophosphamide 38Surgical Procedures, Operative 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Neoplasms × Glucocorticoids × Clear all
NCT04209218 2025-07-31

Intraoperative Blood Pressure Management and Dexamethasone in Lung Cancer Surgery

Peking University First Hospital

Phase NA Recruiting
1,988 enrolled
Thoracic

Lung Neoplasms, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡